News

MacroGenics, Inc. Investors Urged for Legal Deadlines Awareness

MacroGenics, Inc. Investors Urged for Legal Deadlines Awareness

Attention MacroGenics Investors

MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company dedicated to creating and selling innovative treatments, is currently facing an ongoing securities class action lawsuit. If you own or have owned shares of MacroGenics within a certain timeframe, it's important to be aware of this situation, as it may significantly affect your legal rights.

Understanding the Lawsuit

The lawsuit claims that MacroGenics provided misleading information regarding the interim safety data from their TAMARACK Phase 2 study. This study looked into a drug called vobramitamab duocarmazine, intended for treating prostate cancer. These misleading statements could have resulted in financial losses for investors who purchased shares in the company.

Your Rights as an Investor

If you bought shares of MacroGenics, particularly between March 7, 2024, and May 9, 2024, it’s essential to understand your rights. Consulting with legal experts can help clarify if you can be involved as a lead plaintiff in this lawsuit. A lead plaintiff represents the interests of other investors throughout the litigation process.

Key Deadlines

Investors should be aware of important deadlines tied to this lawsuit. If you're considering becoming a lead plaintiff, you must submit the required paperwork by September 24, 2024. Even if you decide not to take action, it’s crucial to know that you can still be part of the class action without losing your rights to any potential recovery.

How to Get Involved

If you feel affected by the recent developments surrounding MacroGenics, it's advisable to reach out to legal professionals. Many law firms, including Bernstein Liebhard LLP, offer contingency fee arrangements. This means investors won't incur upfront costs, making it easier for every shareholder to pursue justice.

Why Trust Bernstein Liebhard LLP?

Bernstein Liebhard LLP is a well-regarded law firm known for its strong track record in securities litigation. Since 1993, they've helped clients recover over $3.5 billion. Their commitment extends to both individual investors and large public and private pension funds, demonstrating their capability in achieving positive outcomes.

What to Expect Moving Forward

As the lawsuit develops, shareholders of MacroGenics, Inc. (NASDAQ: MGNX) should stay informed about any updates. Keeping an eye on the company’s communications and engaging with investor relations will provide vital information regarding the lawsuit and its potential effects on your investment. Staying connected with legal representatives is also important to understand your rights and responsibilities as part of the class action.

Frequently Asked Questions

1. What is the class action lawsuit against MacroGenics about?

The lawsuit claims that MacroGenics provided misleading information about the safety data linked to its prostate cancer treatment, resulting in financial losses for investors.

2. How do I know if I'm eligible to participate?

If you purchased shares of MacroGenics between March 7, 2024, and May 9, 2024, you might be eligible to take part in the lawsuit.

3. What is the deadline for filing paperwork?

The deadline to file as a lead plaintiff is September 24, 2024.

4. What are the costs involved in pursuing this lawsuit?

Bernstein Liebhard LLP operates on a contingency fee basis, meaning you won’t pay fees unless you recover funds.

5. How can I contact investor relations for more information?

You can reach out to Peter Allocco at (212) 951-2030 for assistance with your investments in MacroGenics, Inc.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AmeriTrust's Medicaid Platform Reaches All U.S. States

Updated Category News Views 3

Breaking New Ground in Medicaid Applications Brace yourself, healthcare folk! AmeriTrust Solutions just rolled out its Medicaid application platform across all 50 states, and not a minute too soon. With the ink still wet on H.R.1, hospitals and revenue cycle management (RCM) partners need all the help they can get navigating Medicaid's twisting corridors. AmeriTrust is...

Continue Reading
Robotic Tiling Deal Boosts Foley Tile's National Reach

Updated Category News Views 2

Robots Changing the Tiling Game Human Friendly Robotics (HFR) just dropped a game-changer—a $3.55 million deal with Foley Tile that's shaking up the tiling scene. For folks not glued to the market, this means HFR's Tyler robots are now neck-deep in Arizona soil, tasked with tiling jobs that once had the Foley crew running ragged. The Motherload of Opportunities Jerry...

Continue Reading
ThreatLocker Launches Global AI Awareness Campaign

Updated Category News Views 2

Kicking Off with Pop Culture Pizzazz Ah, the sweet sound of a campaign that knows how to tug at the heartstrings of nostalgia. ThreatLocker has gotten creative with its latest strategy to get people buzzing about AI safety. They're unleashing a worldwide campaign themed around 'Terminator 2.' Now that's a throwback! If you've ever caught yourself wide-eyed at the edge of...

Continue Reading
Centrus Energy to Discuss Q3 Earnings on Nov 5 Call

Updated Category News Views 0

Centrus Energy Prepares for Earnings Call You ever feel that twinge in your gut right before a big disclosure? Well, that's where Centrus Energy’s about to take us as they gear up for their quarterly earnings call. On November 5th, bright and early at 8:30 a.m. Eastern Time, NYSE:LEU will be in the spotlight, laying out its Q3 results for all us nose-to-the-grindstone...

Continue Reading
Voter Power Flexes with Early Voting Celebrations

Updated Category News Views 6

Voter Engagement Hits a New High with Nationwide Parties Well, look at that—voter turnout's got its own party scene now, and it's making waves. As Vote Early Day approaches, the folks at When We All Vote are cranking up the volume on civic engagement with what's touted as the biggest Party at the Polls program yet. With almost 700 get-togethers riffing across the U.S.,...

Continue Reading
Essity's Q3 2026: Profits Hold Firm Amid Challenges

Updated Category News Views 5

Essity's Balance Act in Q3: A Close Examination No looking through rose-tinted glasses here—Essity navigated the third quarter of 2026 with mixed indicators. Despite the broad strokes of stability, there's plenty beneath the surface worth a seasoned investor's eye. The company's net sales inched up by 4.1% to SEK 36,060 million. A nice figure, sure, but if you peek...

Continue Reading
Nuix debuts AI Agent with audit trail for added trust

Updated Category News Views 3

AI in Legal and Investigative Analysis: A Leap Forward Here comes Nuix with a shiny new toy—Nuix Neo AI Agent. And it ain't just any tool. This thing's built to dive through mountains of unstructured data and spit out answers backed by its trail of breadcrumbs. From legal teams to auditors and everyone in between, it'll lay out the paths it took to get to its...

Continue Reading
AI Tool circMAC Enhances MicroRNA Mapping on circRNAs

Updated Category News Views 3

Mapping the Complex Maze of MicroRNA on Circular RNAs Pusan National University's brainiacs have cooked up something spicy for the bioinformatics world. They've developed this snazzy AI tool, circMAC, to unravel microRNA binding mysteries on circular RNAs. 'Why’s this such a big deal?' you ask. Well, these loop-shaped critters, circRNAs, play a backstage role in gene...

Continue Reading
UBCF Extends Pink Bag Event for Breast Cancer Aid

Updated Category News Views 2

Community Need Drives Event Extension October in Jonesboro just got a bit more hopeful for breast cancer survivors—it's not just about awareness anymore; it's about action. The United Breast Cancer Foundation (UBCF) has decided to extend its popular Pink Bag free shopping event through October 30th. What spurred this decision? Well, the overwhelming community demand,...

Continue Reading
CRISPR Ignite: KU Leuven, ERS Genomics Strike Deal

Updated Category News Views 3

Unpacking the CRISPR/Cas9 Agreement Well, here's a fresh chapter in the realm of genetic tinkering. ERS Genomics, the gatekeeper of CRISPR licenses, has put ink to paper with KU Leuven. For those not glued to the labyrinth of genome editing, this might sound like another white-coat shuffle, but it's a pretty big deal. We're talking about CRISPR/Cas9—one of the most...

Continue Reading

Top 5 Most Recently Viewed Articles

Transform Your Investments: The Surprising Growth of BJ's Wholesale

Updated Category News Views 324

The Remarkable Rise of BJ's Wholesale Club Stock BJ's Wholesale Club (NYSE: BJ) has shown an extraordinary performance in the stock market over the past five years, significantly surpassing overall market averages. With a staggering annualized growth rate of 20.47%, investors have enjoyed an impressive average annual return of 33.25%. This dramatic rise has helped BJ's...

Continue Reading
Hyzon Motors Achieves Milestone with ISO Certification Success

Updated Category News Views 75

Hyzon Embraces Quality with ISO 9001 Certification Hyzon Motors Inc. (NASDAQ: HYZN), renowned for its innovative hydrogen fuel cell systems for commercial vehicles, is excited to announce that it has achieved ISO 9001:2015 certification. This significant milestone was confirmed through an evaluation by Bureau Veritas, a respected global leader in testing, inspection, and...

Continue Reading
Investing in Nature's Future: Chi-Cal River Fund Grants

Updated Category News Views 329

Chi-Cal Rivers Fund Announces Major Conservation Initiative In an inspiring move for the Chicago-Calumet region, the Chi-Cal Rivers Fund has announced a significant investment of $2.1 million in conservation grants aimed at enhancing local habitats and greenspaces. This funding, which serves not only to protect vital ecosystems but also to engage communities, is poised to...

Continue Reading
Nouveau Monde Graphite Advances Phase-2 Matawinie Mine Project

Updated Category News Views 159

Nouveau Monde Graphite Moves Forward with Phase-2 Matawinie Mine Project Nouveau Monde Graphite Inc. (NYSE: NMG) is making noteworthy strides in preparing for the construction of the Phase-2 Matawinie Mine. Through careful procurement, thorough engineering, and investments in local community initiatives, NMG is dedicated to ensuring the successful launch of this...

Continue Reading
BP Partners with ABS for Advanced Kaskida FPU Services

Updated Category News Views 213

BP Teams Up with ABS for Kaskida Project BP plc, a leading energy company from the UK, has enlisted the expertise of the American Bureau of Shipping (ABS) to gain critical support for its floating production unit (FPU) linked to the ambitious Kaskida development in the Gulf of Mexico. This initiative marks BP's ongoing commitment to deepwater projects, representing their...

Continue Reading